BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Long Term Investor Notice: Investigation of Potential Wrongdoing
An investigation on behalf of current long-term investors in shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) concerning potential breaches of fiduciary duties by certain directors and officers of BioXcel Therapeutics, Inc. was announced.
View full press release